Drug Shortage Report for ROPIVACAINE HYDROCHLORIDE INJECTION, USP
Report ID | 147731 |
Drug Identification Number | 02439409 |
Brand name | ROPIVACAINE HYDROCHLORIDE INJECTION, USP |
Common or Proper name | Ropivacaine Hydrochloride Injection, USP 10 mg/mL Ampoule 20 mL |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | ROPIVACAINE HYDROCHLORIDE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | EPIDURAL EPIDURAL |
Packaging size | 20mL |
ATC code | N01BB |
ATC description | ANESTHETICS, LOCAL |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-10-26 |
Actual start date | 2021-10-26 |
Estimated end date | 2021-12-20 |
Actual end date | 2021-12-30 |
Shortage status | Resolved |
Updated date | 2021-12-31 |
Company comments | Our Ropivacaine Hydrochloride Injection, USP 10 mg/mL Ampoule 10 mL is available for substitution. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2021-12-31 | English | Compare |
v8 | 2021-12-22 | French | Compare |
v7 | 2021-12-22 | English | Compare |
v6 | 2021-11-16 | French | Compare |
v5 | 2021-11-16 | English | Compare |
v4 | 2021-10-27 | English | Compare |
v3 | 2021-10-21 | French | Compare |
v2 | 2021-10-21 | French | Compare |
v1 | 2021-10-21 | English | Compare |
Showing 1 to 9 of 9